- Who can participate: Adults aged 18 and older with a confirmed diagnosis of the condition being studied are eligible to participate.
- Study details: Participants will receive either the investigational treatment or a placebo. The study will involve regular monitoring and assessments.
The prescreener preview is complete. You may now close the preview.

